Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  FSD Pharma Inc    HUGE   CA35954B1076

FSD PHARMA INC (HUGE)
My previous session
Most popular
Delayed Quote. Delayed  - 01/21 04:04:59 pm
0.32 CAD   -1.54%
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector news

FSD Pharma : Announces Holdings in Cannara Biotech Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/11/2019 | 04:27pm EST

TORONTO, Jan. 11, 2019 /CNW/ - FSD Pharma ("FSD") announced today that, in connection with the business combination (the "Business Combination") completed on December 31, 2018 among Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) (the "Issuer"), Cannara Biotech Inc. and 11038427 Canada Inc., FSD Pharma, directly or indirectly, acquired ownership of 85,003,750 common shares ("Common Shares") of the Issuer, representing 12.25% of the issued and outstanding Common Shares of the Issuer.

FSD holds 75,003,750 of the Common Shares through its wholly-owned subsidiary, FV Pharma. The Common Shares are held in escrow in accordance with the rules of the Canadian Securities Exchange. Immediately prior to the completion of the Business Combination, FSD did not own or exercise control or direction over any securities of the Issuer.   

FSD holds and controls its Common Shares of the Issuer for investment purposes only and FSD may increase or decrease its beneficial ownership or control over the Common Shares of the Issuer, which it may do, subject to the terms of the escrow arrangements, from time to time, depending on market or other conditions and to the extent deemed advisable in light of its general investment strategy.

This news release is being disseminated as required by National Instrument 62-103 - The Early Warning System and Related Take-Over Bids and Insider Reporting Issues in connection with the anticipated filing of an early warning report (the "Early Warning Report"). A copy of the Early Warning Report will be available on SEDAR under the Issuer's issuer profile at www.sedar.com and can be obtained by contacting the Company as set out below.

SOURCE FSD Pharma Inc.

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FSD PHARMA INC
01/15FSD Pharma, Plans for Becoming the Largest Producer in the World, CEO Clip Vi..
NE
01/14FSD PHARMA : Congratulates Cannara Biotech for Its Listing and Commencement of T..
AQ
01/11FSD PHARMA : Announces Holdings in Cannara Biotech Inc.
AQ
01/08FSD PHARMA : Completes Harvest and Passes Analytical Testing of Second Lot
BU
2018InvestmentPitch Media Video Discusses Licensed Cannabis Producer FSD Pharma's..
NE
2018FSD PHARMA : Responds to Therapix Termination of Binding LOI
BU
2018CANNTAB THERAPEUTICS : & FSD Pharma Make Cannabis More Palatable for Doctors -- ..
AQ
2018FSD PHARMA : Efforts underway to convert 10 Coffee Time shops into cannabis stor..
AQ
2018FSD PHARMA : Announces Strategic Investment in Huge Shops
BU
2018FSD PHARMA : Congratulates High Tide for Its Listing and Commencement of Trading..
BU
More news
Chart FSD PHARMA INC
Duration : Period :
FSD Pharma Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Raza Bokhari Co-Chairman & Chief Executive Officer
Rupert Haynes Co-Chairman & Chief Executive Officer
Anthony J. Durkacz Co-Chairman
Donal Carroll Chief Financial Officer
Vladimir Klacar Director
Sector and Competitors
1st jan.Capitalization (M$)
FSD PHARMA INC12.28%0
CANOPY GROWTH CORP56.92%14 867
AURORA CANNABIS INC23.89%6 389
BEIJING TONGRENTANG CO., LTD.-1.53%5 365
DONG-E-E-JIAO CO LTD--.--%3 919
HUTCHISON CHINA MEDITECH LIMITED-3.57%2 921